Rights and permissions
About this article
Cite this article
Everolimus-eluting stents the most “economically attractive“ option. Pharmacoecon. Outcomes News 657, 5 (2012). https://doi.org/10.2165/00151234-201206570-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206570-00011